Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 3

Effect of angiotensin II blockade on central blood pressure and arterial stiffness in subjects with hypertension

Authors Safar M

Published 3 December 2010 Volume 2010:3 Pages 167—174


Review by Single anonymous peer review

Peer reviewer comments 2

Michel E Safar
Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Hôtel-Dieu Centre de Diagnostic et de Thérapeutique, Paris, France

Abstract: In hypertension, the blood pressure curve may be divided into two sets of components. The first set is mean arterial pressure, steady flow, and vascular resistance, thus acting on small arteries; the second set refers to large arteries, hence to pulse pressure, arterial stiffness, and wave reflections. The angiotensin-converting enzyme (ACE) inhibitor perindopril not only reduces mean arterial pressure but also acts specifically on pulse pressure. The effect on pulse pressure predominates on central rather than peripheral (brachial) large arteries, reducing aortic stiffness and most wave reflections. Such hemodynamic changes are not observed with standard ß-blockade, which reduces aortic stiffness and brachial systolic and pulse pressure but not central pulse pressure and wave reflections. In hypertensive subjects, perindopril and other ACE inhibitors seem to predict more consistently the reduction of cardiovascular events, mainly of cardiac origin, than standard ß-blockers alone. This effect is associated with the important biochemical finding that mechanotransductions of angiotensin and ß-blockade are markedly different, acting in the former specifically on the α5ß1 integrin complex and on the fibronectin ligand of arterial vessels.

Keywords: antihypertensive therapy, arterial stiffness, renal function

Creative Commons License © 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.